Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 6.56 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 8.52 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 6.98 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 5.06 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 10.1 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 6.58 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 5.89 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 4.96 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 0.0 | BCD100322A01 | 9.62 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 0.5 | BCD100322A03 | 5.67 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 1.0 | BCD100322A07 | 8.25 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 2.0 | BCD100322A11 | 8.45 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 4.0 | BCD100322A15 | 12.2 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 8.0 | BCD100322A19 | 12.7 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 12.0 | BCD100322A23 | 11.1 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 24.0 | BCD100322A27 | 10.1 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 10.2 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 9.57 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 7.2 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 6.67 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 6.53 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 7.31 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 8.36 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 0.5 | BCD100322A04 | 12.2 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 1.0 | BCD100322A08 | 8.1 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 2.0 | BCD100322A12 | 10.8 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 4.0 | BCD100322A16 | 7.21 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 8.0 | BCD100322A20 | 10.3 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 12.0 | BCD100322A24 | 12.8 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 24.0 | BCD100322A28 | 9.45 | pmol/sample |